文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

July 2017 ENCALS statement on edaravone.

作者信息

Al-Chalabi Ammar, Andersen Peter M, Chandran Siddharthan, Chio Adriano, Corcia Philippe, Couratier Philippe, Danielsson Olof, de Carvalho Mamede, Desnuelle Claude, Grehl Torsten, Grosskreutz Julian, Holmøy Trygve, Ingre Caroline, Karlsborg Merete, Kleveland Grethe, Koch Jan Christoph, Koritnik Blaz, KuzmaKozakiewicz Magdalena, Laaksovirta Hannu, Ludolph Albert, McDermott Christopher, Meyer Thomas, Mitre Ropero Bernardo, Mora Pardina Jesus, Nygren Ingela, Petri Susanne, Povedano Panades Mónica, Salachas Francois, Shaw Pamela, Silani Vincenzo, Staaf Gert, Svenstrup Kirsten, Talbot Kevin, Tysnes Ole-Bjørn, Van Damme Philip, van der Kooi Anneke, Weber Markus, Weydt Patrick, Wolf Joachim, Hardiman Orla, van den Berg Leonard H

机构信息

a Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience , King's College London , London , UK.

b Department of Pharmacology and Clinical Neuroscience , Umeä University , Umeä , Sweden.

出版信息

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4.

DOI:10.1080/21678421.2017.1369125
PMID:28975816
Abstract
摘要

相似文献

[1]
July 2017 ENCALS statement on edaravone.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-11

[2]
Edaravone (Radicava) for ALS.

Med Lett Drugs Ther. 2017-11-6

[3]
Edaravone in ALS.

Exp Neurol. 2009-6

[4]
Edaravone and its clinical development for amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[5]
Edaravone: a new hope for deadly amyotrophic lateral sclerosis.

Drugs Today (Barc). 2018-6

[6]
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[7]
Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[8]
A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[9]
Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).

Amyotroph Lateral Scler Frontotemporal Degener. 2017-10

[10]
Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis.

Expert Opin Pharmacother. 2017-5

引用本文的文献

[1]
Effect of Edaravone Therapy on Amyotrophic Lateral Sclerosis Functional Rating Score (ALS-FRS) in Patients of Amyotrophic Lateral Sclerosis (ALS) in Central India: A Retrospective Open Label Study.

Ann Neurosci. 2025-7-29

[2]
Diagnostic elements in amyotrophic lateral sclerosis: A case report.

Biomed Rep. 2024-8-1

[3]
Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Acta Neurol Belg. 2024-6

[4]
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis.

BMJ. 2023-10-27

[5]
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder.

Biomedicines. 2023-5-31

[6]
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Neurotherapeutics. 2022-7

[7]
Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle.

Cells. 2022-1-25

[8]
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.

JAMA Neurol. 2022-2-1

[9]
A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis.

Front Neurol. 2021-11-8

[10]
Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study.

Neurol Sci. 2022-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索